Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
LH · NYSE · Healthcare
Fundamental quality
50
out of 100
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its financial strength weighs in its favor, while its growth drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | $13,136M | $2,377M | $2,688M | $3,945M |
| 2022 | $11,864M | $1,279M | $1,527M | $5,020M |
| 2023 | $12,162M | $418M | $874M | $4,518M |
| 2024 | $13,009M | $746M | $1,096M | $4,813M |
| 2025 | $13,952M | $877M | $1,206M | $5,052M |
Between 2021 and 2025, revenue went from $13,136M to $13,952M (+6%) and net income went from $2,377M to $877M (-63%).
Annual figures in U.S. dollars per SEC filings. Net debt is total debt minus cash.
Is Labcorp Holdings Inc. a profitable company?
Labcorp Holdings Inc. is profitable, with a net margin of 6.7%, though a thin one.
Does Labcorp Holdings Inc. have a lot of debt?
A moderate level: its net debt is 2.52 times its EBITDA.
Is Labcorp Holdings Inc. growing?
Its revenue has grown 5.6% annualized in recent years.
Does Labcorp Holdings Inc. generate cash?
Yes. It converts about 9.8% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Labcorp Holdings Inc. cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →